Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol Addition to Tiotropium in COPD
NCT02242240Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2001
- Primary completion
- Dec 2001
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Mar 2001; status: completed.
02
Drugs
formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02242240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242240.